snb personal page - To The Moon

snb

snb

No personal profile

49Follow

2Followers

0Topic

0Badge

2021-08-01

Nice

Why Oracle Stock Could Be Volatile In August

2021-08-16

$Greenvision Acquisition Corp. Rights(GRNVR)$How can i sell this one.This stock is delisted.

2021-07-31

$TAL Education Group(TAL)$buy this good stk

2021-08-02

Nice

China shares jump after worst month in nearly 3 years

2021-07-31

Positive results

Sorry, the original content has been removed

2021-08-07

Watch list

2021-08-05

Going down...until when

2021-08-04

Watchlist

2021-08-03

Kept watchlist

2021-08-02

Sad

India says J&J withdraws proposal for speedy vaccine approval

2021-08-01

Keep watchlist

2021-07-31

Buy this stk

2021-07-31

Buy this

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3583733168961193,"uuid":"3583733168961193","gmtCreate":1620639381299,"gmtModify":1634101904429,"name":"snb","pinyin":"snb","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":49,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":830779358,"gmtCreate":1629103114874,"gmtModify":1676529930630,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRNVR\">$Greenvision Acquisition Corp. Rights(GRNVR)$</a>How can i sell this one.This stock is delisted.","listText":"<a href=\"https://laohu8.com/S/GRNVR\">$Greenvision Acquisition Corp. Rights(GRNVR)$</a>How can i sell this one.This stock is delisted.","text":"$Greenvision Acquisition Corp. Rights(GRNVR)$How can i sell this one.This stock is delisted.","images":[{"img":"https://static.tigerbbs.com/f7c5e1bc32c5629f9abb3b6e60e7af27","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/830779358","isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3564387851823420","authorId":"3564387851823420","name":"ememe","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"content":"I have no Man Cang","text":"I have no Man Cang","html":"I have no Man Cang"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":893228420,"gmtCreate":1628265780360,"gmtModify":1703504343875,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watch list","listText":"Watch list","text":"Watch list","images":[{"img":"https://static.tigerbbs.com/87f227d930393cb90f74ae65676aab38","width":"1080","height":"3279"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893228420","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890408151,"gmtCreate":1628126512973,"gmtModify":1703501672029,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Going down...until when","listText":"Going down...until when","text":"Going down...until when","images":[{"img":"https://static.tigerbbs.com/63fb88b669db74915d3fc40d6a94d1f7","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890408151","isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":807469704,"gmtCreate":1628050783208,"gmtModify":1703500301467,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watchlist","listText":"Watchlist","text":"Watchlist","images":[{"img":"https://static.tigerbbs.com/f3e05fe9d4c70af016eb1fdff5bf58a0","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807469704","isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804854112,"gmtCreate":1627951020036,"gmtModify":1703498364411,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Kept watchlist","listText":"Kept watchlist","text":"Kept watchlist","images":[{"img":"https://static.tigerbbs.com/b2261375a267fff142acb64ecba6883d","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804854112","isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805446022,"gmtCreate":1627902606966,"gmtModify":1703497509997,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805446022","repostId":"2156212196","repostType":4,"repost":{"id":"2156212196","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627890622,"share":"https://www.laohu8.com/m/news/2156212196?lang=&edition=full","pubTime":"2021-08-02 15:50","market":"sh","language":"en","title":"China shares jump after worst month in nearly 3 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2156212196","media":"Reuters","summary":"SSEC up 1.97%, CSI300 up 2.55%\nForeigners lend support as net buyers through Stock Connect\nNew Delta","content":"<ul>\n <li>SSEC up 1.97%, CSI300 up 2.55%</li>\n <li>Foreigners lend support as net buyers through Stock Connect</li>\n <li>New Delta variant virus cases continue to rise</li>\n <li>China government bond yields lowest in more than 1 year</li>\n</ul>\n<p>SHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.</p>\n<p>The Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index&nbsp;ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.</p>\n<p>The gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.</p>\n<p>\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.</p>\n<p>\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"</p>\n<p>Both the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.</p>\n<p>Those concerns also weighed on the fixed income market, where benchmark Chinese government bond <a href=\"https://laohu8.com/S/CGB.AU\">$(CGB.AU)$</a> yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.</p>\n<p>Adding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.</p>\n<p>But by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.</p>\n<p>Data from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).</p>\n<p>\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.</p>\n<p>($1 = 6.4631 Chinese yuan)</p>\n<p>(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China shares jump after worst month in nearly 3 years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina shares jump after worst month in nearly 3 years\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-02 15:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SSEC up 1.97%, CSI300 up 2.55%</li>\n <li>Foreigners lend support as net buyers through Stock Connect</li>\n <li>New Delta variant virus cases continue to rise</li>\n <li>China government bond yields lowest in more than 1 year</li>\n</ul>\n<p>SHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.</p>\n<p>The Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index&nbsp;ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.</p>\n<p>The gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.</p>\n<p>\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.</p>\n<p>\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"</p>\n<p>Both the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.</p>\n<p>Those concerns also weighed on the fixed income market, where benchmark Chinese government bond <a href=\"https://laohu8.com/S/CGB.AU\">$(CGB.AU)$</a> yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.</p>\n<p>Adding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.</p>\n<p>But by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.</p>\n<p>Data from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).</p>\n<p>\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.</p>\n<p>($1 = 6.4631 Chinese yuan)</p>\n<p>(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156212196","content_text":"SSEC up 1.97%, CSI300 up 2.55%\nForeigners lend support as net buyers through Stock Connect\nNew Delta variant virus cases continue to rise\nChina government bond yields lowest in more than 1 year\n\nSHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.\nThe Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.\nThe gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.\n\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.\n\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"\nBoth the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.\nThose concerns also weighed on the fixed income market, where benchmark Chinese government bond $(CGB.AU)$ yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.\nAdding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.\nBut by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.\nData from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).\n\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.\n($1 = 6.4631 Chinese yuan)\n(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)","news_type":1},"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805448303,"gmtCreate":1627902563202,"gmtModify":1703497508515,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805448303","repostId":"2156191887","repostType":4,"repost":{"id":"2156191887","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627893983,"share":"https://www.laohu8.com/m/news/2156191887?lang=&edition=full","pubTime":"2021-08-02 16:46","market":"us","language":"en","title":"India says J&J withdraws proposal for speedy vaccine approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2156191887","media":"Reuters","summary":"(Adds details, background)\nBENGALURU, Aug 2 (Reuters) - India's drug regulator said on Monday that J","content":"<p>(Adds details, background)</p>\n<p>BENGALURU, Aug 2 (Reuters) - India's drug regulator said&nbsp;on Monday that Johnson &amp; Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.</p>\n<p>The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports&nbsp;of rare blood clots.</p>\n<p>The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.</p>\n<p>\"This team is in continuous dialogue with Pfizer, Moderna and Johnson &amp; Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.</p>\n<p>Johnson &amp; Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.</p>\n<p>As of July 31, Johnson &amp; Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> , and Moderna Inc have already sought full approval of their vaccines with the FDA.</p>\n<p>In India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.</p>\n<p>(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>India says J&J withdraws proposal for speedy vaccine approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndia says J&J withdraws proposal for speedy vaccine approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-02 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Adds details, background)</p>\n<p>BENGALURU, Aug 2 (Reuters) - India's drug regulator said&nbsp;on Monday that Johnson &amp; Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.</p>\n<p>The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports&nbsp;of rare blood clots.</p>\n<p>The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.</p>\n<p>\"This team is in continuous dialogue with Pfizer, Moderna and Johnson &amp; Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.</p>\n<p>Johnson &amp; Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.</p>\n<p>As of July 31, Johnson &amp; Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> , and Moderna Inc have already sought full approval of their vaccines with the FDA.</p>\n<p>In India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.</p>\n<p>(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156191887","content_text":"(Adds details, background)\nBENGALURU, Aug 2 (Reuters) - India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.\nThe U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots.\nThe drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.\n\"This team is in continuous dialogue with Pfizer, Moderna and Johnson & Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.\nJohnson & Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.\nAs of July 31, Johnson & Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, BioNTech SE , and Moderna Inc have already sought full approval of their vaccines with the FDA.\nIn India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.\n(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802438840,"gmtCreate":1627794119480,"gmtModify":1703495995058,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep watchlist","listText":"Keep watchlist","text":"Keep watchlist","images":[{"img":"https://static.tigerbbs.com/1d83e9dc6c292359747107d732b0a7d2","width":"1080","height":"3487"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802438840","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802572548,"gmtCreate":1627791759984,"gmtModify":1703495956271,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/802572548","repostId":"1159296868","repostType":4,"repost":{"id":"1159296868","pubTimestamp":1627786610,"share":"https://www.laohu8.com/m/news/1159296868?lang=&edition=full","pubTime":"2021-08-01 10:56","market":"us","language":"en","title":"Why Oracle Stock Could Be Volatile In August","url":"https://stock-news.laohu8.com/highlight/detail?id=1159296868","media":"InvestorPlace","summary":"Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce consider","content":"<blockquote>\n Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n</blockquote>\n<p>Once considered a laggard company in the world of technology,<b>Oracle</b>&nbsp;(NYSE:<b>ORCL</b>) stock has made a comeback as one of the best-performing tech names of 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/1e4fb922d429b71a40534256e2dff304\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: Jonathan Weiss / Shutterstock.com</p>\n<p>It was the original champion of database technology. Now Oracle is becoming an emerging force in both backend infrastructure technologies and software-as-a-service (SaaS). In other words, management is proving that what is considered outdated can quickly become hot again in the tech stock space.</p>\n<p>Investors have not been shy to bid ORCL stock up this year. Growth expectations mainly revolve around the cloud computing business. As a result, ORCL stock has soared by 56% over the last 12 months.</p>\n<p>And the rally accelerated after Oracle recently released its fourth-quarter and FY21 results. As a result, the shares hit a record high of $91.20. It currently trades around $87, up 35% in 2021. The current price supports a dividend yield of about 1.3%.</p>\n<p>Thanks to its success in the cloud, Oracle has outperformed many tech stocks currently underperforming the broader market this year. However, in the short run, ORCL stock is likely to be volatile and could see profit-taking</p>\n<p>Yet, long-term investors looking to generate lucrative returns in the rest of 2021 and beyond may consider buying the dips. Here’s why.</p>\n<p><b>How Recent Earnings Came</b></p>\n<p>Founded in 1977, Oracle is well-known for pioneering the first commercial SQL-based relational database management system. Now, with 430,000 customers in 175 countries, the tech giant provides database technology and enterprise resource planning (ERP) software to businesses and global governments. Its market capitalization&nbsp; stands at $246 billion.</p>\n<p>Oracle released&nbsp;fourth-quarter resultsin mid-June. Total revenue increased 8% year-over-year to $11.2 billion. Non-GAAP net income went up buy 20% to $4.5 billion, and non-GAAP earnings per share soared 29% to $1.54.</p>\n<p>In fiscal 2021, Oracle generated almost $13.8 billion in free cash flow. As a result, management invested heavily in stock buybacks. Excluding the $3 billion spent on dividends, it bought back 329 million shares at a cost of $21 billion in the past year. Cash and equivalents ended the fiscal year at $30.1 billion.</p>\n<p>On the results, CEO Safra Catz remarked, “Our Q4 performance was absolutely outstanding with total revenue beating guidance by nearly $200 million, and non-GAAP earnings per share beating guidance by $0.24.”</p>\n<p>Cloud apps saw 20% to 30% growth. Yet, it has not led to a significant increase in overall revenue for the fiscal year 2021. Oracle’s revenue of $40.5 billion grew only by 4% compared to the previous year.</p>\n<p>ORCL stock is currently trading at 19x forward price-earnings multiple and 6.5x current sales. The 12-month price target range for Oracle stock extends from $60 to $115. The median estimate of $80 would mean a decline of about 9% from the current levels. Therefore, short-term investors could see the shares come under pressure.</p>\n<p><b>Long-Term Tailwinds For Oracle Stock</b></p>\n<p>Despite the potential short-term volatility, there are many reasons for investors to consider ORCL stock. It has a broad portfolio addressing different spectrums of enterprise technology. Revenues have been gaining momentum after the company has shifted resources to the cloud space.</p>\n<p>Management regards the cloud in terms of platform, application, and infrastructure layers. Put another way, Oracle offers a complete package that may lead to a even a stronger competitive advantage in the long term.</p>\n<p>The company has recently announced plans to increase spending on data centers. It will double capital expenditures to almost $4 billion. Investors are hoping this heavy spending will boost the cloud businesses.</p>\n<p>Market research firm&nbsp;Research and Markets&nbsp;predicts cloud spending could grow at a compound annual growth rate of 17.5% through 2025. Although this implies a massive opportunity, Oracle currently has a minor share of the broad cloud market.</p>\n<p>The company still trails behind the market leader<b>Amazon</b>(NASDAQ:<b>AMZN</b>) as well as other&nbsp; competitors<b>Microsoft</b>(NASDAQ:<b>MSFT</b>) and&nbsp;<b>Alphabet</b>&nbsp;(NASDAQ:<b>GOOG</b>, NASDAQ:<b>GOOGL</b>). Recent quarterly metrics from these tech giants have shown the importance of cloud applications and services for revenues.</p>\n<p>If management were to continue its recent success, it would be possible to see Oracle grow its market cap to rapidly in the coming quarters as well.</p>\n<p><b>The Bottom Line on ORCL Stock</b></p>\n<p>Oracle’s revenue mix now focuses more on subscriptions, especially in the cloud space. Investors would like to see the bottom line grow in the coming quarters. However, it might still be several quarters before management’s efforts translate into higher earnings.</p>\n<p>Although I remain bullish on ORCL stock for the long run, I expect some profit-taking in the coming weeks Interested investors could regard any drop toward the $80 to $82 level as a better entry point.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Oracle Stock Could Be Volatile In August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Oracle Stock Could Be Volatile In August\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce considered a laggard company in the world of technology,Oracle (NYSE:ORCL) stock has made a comeback as one ...</p>\n\n<a href=\"https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ORCL":"甲骨文"},"source_url":"https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159296868","content_text":"Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce considered a laggard company in the world of technology,Oracle (NYSE:ORCL) stock has made a comeback as one of the best-performing tech names of 2021.\nSource: Jonathan Weiss / Shutterstock.com\nIt was the original champion of database technology. Now Oracle is becoming an emerging force in both backend infrastructure technologies and software-as-a-service (SaaS). In other words, management is proving that what is considered outdated can quickly become hot again in the tech stock space.\nInvestors have not been shy to bid ORCL stock up this year. Growth expectations mainly revolve around the cloud computing business. As a result, ORCL stock has soared by 56% over the last 12 months.\nAnd the rally accelerated after Oracle recently released its fourth-quarter and FY21 results. As a result, the shares hit a record high of $91.20. It currently trades around $87, up 35% in 2021. The current price supports a dividend yield of about 1.3%.\nThanks to its success in the cloud, Oracle has outperformed many tech stocks currently underperforming the broader market this year. However, in the short run, ORCL stock is likely to be volatile and could see profit-taking\nYet, long-term investors looking to generate lucrative returns in the rest of 2021 and beyond may consider buying the dips. Here’s why.\nHow Recent Earnings Came\nFounded in 1977, Oracle is well-known for pioneering the first commercial SQL-based relational database management system. Now, with 430,000 customers in 175 countries, the tech giant provides database technology and enterprise resource planning (ERP) software to businesses and global governments. Its market capitalization  stands at $246 billion.\nOracle released fourth-quarter resultsin mid-June. Total revenue increased 8% year-over-year to $11.2 billion. Non-GAAP net income went up buy 20% to $4.5 billion, and non-GAAP earnings per share soared 29% to $1.54.\nIn fiscal 2021, Oracle generated almost $13.8 billion in free cash flow. As a result, management invested heavily in stock buybacks. Excluding the $3 billion spent on dividends, it bought back 329 million shares at a cost of $21 billion in the past year. Cash and equivalents ended the fiscal year at $30.1 billion.\nOn the results, CEO Safra Catz remarked, “Our Q4 performance was absolutely outstanding with total revenue beating guidance by nearly $200 million, and non-GAAP earnings per share beating guidance by $0.24.”\nCloud apps saw 20% to 30% growth. Yet, it has not led to a significant increase in overall revenue for the fiscal year 2021. Oracle’s revenue of $40.5 billion grew only by 4% compared to the previous year.\nORCL stock is currently trading at 19x forward price-earnings multiple and 6.5x current sales. The 12-month price target range for Oracle stock extends from $60 to $115. The median estimate of $80 would mean a decline of about 9% from the current levels. Therefore, short-term investors could see the shares come under pressure.\nLong-Term Tailwinds For Oracle Stock\nDespite the potential short-term volatility, there are many reasons for investors to consider ORCL stock. It has a broad portfolio addressing different spectrums of enterprise technology. Revenues have been gaining momentum after the company has shifted resources to the cloud space.\nManagement regards the cloud in terms of platform, application, and infrastructure layers. Put another way, Oracle offers a complete package that may lead to a even a stronger competitive advantage in the long term.\nThe company has recently announced plans to increase spending on data centers. It will double capital expenditures to almost $4 billion. Investors are hoping this heavy spending will boost the cloud businesses.\nMarket research firm Research and Markets predicts cloud spending could grow at a compound annual growth rate of 17.5% through 2025. Although this implies a massive opportunity, Oracle currently has a minor share of the broad cloud market.\nThe company still trails behind the market leaderAmazon(NASDAQ:AMZN) as well as other  competitorsMicrosoft(NASDAQ:MSFT) and Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL). Recent quarterly metrics from these tech giants have shown the importance of cloud applications and services for revenues.\nIf management were to continue its recent success, it would be possible to see Oracle grow its market cap to rapidly in the coming quarters as well.\nThe Bottom Line on ORCL Stock\nOracle’s revenue mix now focuses more on subscriptions, especially in the cloud space. Investors would like to see the bottom line grow in the coming quarters. However, it might still be several quarters before management’s efforts translate into higher earnings.\nAlthough I remain bullish on ORCL stock for the long run, I expect some profit-taking in the coming weeks Interested investors could regard any drop toward the $80 to $82 level as a better entry point.","news_type":1},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802576744,"gmtCreate":1627791719488,"gmtModify":1703495954972,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good suggestion","listText":"Good suggestion","text":"Good suggestion","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802576744","repostId":"1173075225","repostType":4,"repost":{"id":"1173075225","pubTimestamp":1627704977,"share":"https://www.laohu8.com/m/news/1173075225?lang=&edition=full","pubTime":"2021-07-31 12:16","market":"us","language":"en","title":"5 Best Dividend Stocks to Buy in August","url":"https://stock-news.laohu8.com/highlight/detail?id=1173075225","media":"US News","summary":"In late July, the Dow Jones Industrial Average slid more than 700 points in a single session to log its worst single-day decline since October. Shares have since rebounded, and the majorstock market indexesall continue to flirt with new all-time highs, but it's worth noting that the big gains of the last year or two seem much harder to come by. Specifically, the Dow Jones is more or less flat from where it was at the start of May.That hints that gains could be tougher to score in the months ahea","content":"<p>In late July, the Dow Jones Industrial Average slid more than 700 points in a single session to log its worst single-day decline since October. Shares have since rebounded, and the majorstock market indexesall continue to flirt with new all-time highs, but it's worth noting that the big gains of the last year or two seem much harder to come by. Specifically, the Dow Jones is more or less flat from where it was at the start of May.</p>\n<p>That hints that gains could be tougher to score in the months ahead -- and could be a sign that income-oriented dividend stocks may provide not just stability but also a nice flow of cash to ensure your nest egg keeps growing.</p>\n<p>If you're interested individend stocksright now, here are five that look particularly strong at the start of August:</p>\n<ul>\n <li>EPR Properties (ticker:EPR)</li>\n <li><a href=\"https://laohu8.com/S/NAVI\">Navient Corp</a>. (NAVI)</li>\n <li>Pfizer Inc. (PFE)</li>\n <li>Vedanta Ltd. (VEDL)</li>\n <li>Vistra Corp. (VST)</li>\n</ul>\n<p>[Sign up for stock news with our Invested newsletter.]</p>\n<p><b>EPR Properties (EPR)</b></p>\n<p><b>Dividend yield:</b>5.7%</p>\n<p>EPR is a leading \"net lease\" real estate investment trust, meaning it demands clients pay for ancillary expenses like maintenance or insurance on the properties while it just cashes the rent check. It's not a shopping mall or residential real estate firm, however, and focuses on \"out of home leisure and recreation experiences,\" including movie theaters, beach resorts and ski slopes across more than 40 states. Obviously, with the overall easing of coronavirus restrictions, EPR has been seeing a huge recovery to its business compared with its performance last summer in the throes of lockdowns. Shares are up about 60% year to date, and EPR just resumed a 25 cent quarterly dividend in July. That bodes well both for future performance and future dividends.</p>\n<p><b>Navient Corp. (NAVI)</b></p>\n<p><b>Dividend yield:</b>3.2%</p>\n<p>Student loan provider Navient was not exactly a popular stock a year or two ago amid political discussions ofstudent debtforgiveness, which were followed closely by fears of an economic downturn caused by coronavirus disruptions that would upset the payments of young graduates. The financial firm's quarterly dividend of 16 cents, however, went uninterrupted throughout the upheaval, and now NAVI stock is facing an uptrend considering that both the economic and political outlook have improved. Shares are up a huge 150% or so in the last 12 months, and it still offers a dividend that's more than twice the S&amp;P 500, even after that run.</p>\n<p><b>Pfizer Inc. (PFE)</b></p>\n<p><b>Dividend yield:</b>3.6%</p>\n<p>Big Pharma mainstay Pfizer has outperformed the broader stock market slightly in 2021, continuing to ride high on its high-profile success developing an effective coronavirus vaccine. Given the risk posed by variants of the disease, along with a continued push to vaccinate worldwide now that many developed markets have gotten their shots, investors could continue to see a decent tailwind for PFE in the near term. On top of that, don't forget this $240 billion drugmaker remains <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most dominanthealth care companieson the planet, and one of the most reliable dividend stocks out there with an amazing streak of 330 consecutive quarterly dividends paid to shareholders.</p>\n<p><b>Vedanta Ltd. (VEDL)</b></p>\n<p><b>Dividend yield:</b>5.1%</p>\n<p>Vedanta is an India-based industrial conglomerate that operates a diversified natural resources business spanning oil and gas production as well as coal,silverandcoppermining. It also takes the energy sources it extracts and operates power generation facilities, operating an arm that is a major electric utility in the nation. Given that this stock is in an emerging market and not as large as other materials stocks at only about $14 billion, there's a bit more risk here than in other similar stocks. But with a generous dividend and rising revenues, thanks to the global economic recovery, this stock has been a top performer lately with year-to-date returns of more than 60% in 2021.</p>\n<p><b>Vistra Corp. (VST)</b></p>\n<p><b>Dividend yield:</b>3.1%</p>\n<p>A Texas-based utility company, Vistra is an electricity provider -- one of the most stable businesses on Wall Street. But VST also has modest growth potential as it operates in six of the seven wholesale markets where utilities compete for customers, thanks to deregulation. Right now, it has nearly 5 million residential, commercial and industrial connections in about 20 states. Additionally, it announced construction of a 1,600 megawatt-hour battery energy storage system in California, which has captivated investors. Shares have underperformed year to date in 2021, but are up about 30% from their spring lows -- and continue to offer a generous dividend on top of this short-term momentum.</p>","source":"lsy1627705648360","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Best Dividend Stocks to Buy in August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Best Dividend Stocks to Buy in August\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-31 12:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/5-best-dividend-stocks-buy-175503089.html><strong>US News</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In late July, the Dow Jones Industrial Average slid more than 700 points in a single session to log its worst single-day decline since October. Shares have since rebounded, and the majorstock market ...</p>\n\n<a href=\"https://finance.yahoo.com/news/5-best-dividend-stocks-buy-175503089.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NAVI":"Navient Corp","EPR":"EPR不动产","VST":"Vistra Energy Corp.","VEDL":"Vedanta  Limited"},"source_url":"https://finance.yahoo.com/news/5-best-dividend-stocks-buy-175503089.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173075225","content_text":"In late July, the Dow Jones Industrial Average slid more than 700 points in a single session to log its worst single-day decline since October. Shares have since rebounded, and the majorstock market indexesall continue to flirt with new all-time highs, but it's worth noting that the big gains of the last year or two seem much harder to come by. Specifically, the Dow Jones is more or less flat from where it was at the start of May.\nThat hints that gains could be tougher to score in the months ahead -- and could be a sign that income-oriented dividend stocks may provide not just stability but also a nice flow of cash to ensure your nest egg keeps growing.\nIf you're interested individend stocksright now, here are five that look particularly strong at the start of August:\n\nEPR Properties (ticker:EPR)\nNavient Corp. (NAVI)\nPfizer Inc. (PFE)\nVedanta Ltd. (VEDL)\nVistra Corp. (VST)\n\n[Sign up for stock news with our Invested newsletter.]\nEPR Properties (EPR)\nDividend yield:5.7%\nEPR is a leading \"net lease\" real estate investment trust, meaning it demands clients pay for ancillary expenses like maintenance or insurance on the properties while it just cashes the rent check. It's not a shopping mall or residential real estate firm, however, and focuses on \"out of home leisure and recreation experiences,\" including movie theaters, beach resorts and ski slopes across more than 40 states. Obviously, with the overall easing of coronavirus restrictions, EPR has been seeing a huge recovery to its business compared with its performance last summer in the throes of lockdowns. Shares are up about 60% year to date, and EPR just resumed a 25 cent quarterly dividend in July. That bodes well both for future performance and future dividends.\nNavient Corp. (NAVI)\nDividend yield:3.2%\nStudent loan provider Navient was not exactly a popular stock a year or two ago amid political discussions ofstudent debtforgiveness, which were followed closely by fears of an economic downturn caused by coronavirus disruptions that would upset the payments of young graduates. The financial firm's quarterly dividend of 16 cents, however, went uninterrupted throughout the upheaval, and now NAVI stock is facing an uptrend considering that both the economic and political outlook have improved. Shares are up a huge 150% or so in the last 12 months, and it still offers a dividend that's more than twice the S&P 500, even after that run.\nPfizer Inc. (PFE)\nDividend yield:3.6%\nBig Pharma mainstay Pfizer has outperformed the broader stock market slightly in 2021, continuing to ride high on its high-profile success developing an effective coronavirus vaccine. Given the risk posed by variants of the disease, along with a continued push to vaccinate worldwide now that many developed markets have gotten their shots, investors could continue to see a decent tailwind for PFE in the near term. On top of that, don't forget this $240 billion drugmaker remains one of the most dominanthealth care companieson the planet, and one of the most reliable dividend stocks out there with an amazing streak of 330 consecutive quarterly dividends paid to shareholders.\nVedanta Ltd. (VEDL)\nDividend yield:5.1%\nVedanta is an India-based industrial conglomerate that operates a diversified natural resources business spanning oil and gas production as well as coal,silverandcoppermining. It also takes the energy sources it extracts and operates power generation facilities, operating an arm that is a major electric utility in the nation. Given that this stock is in an emerging market and not as large as other materials stocks at only about $14 billion, there's a bit more risk here than in other similar stocks. But with a generous dividend and rising revenues, thanks to the global economic recovery, this stock has been a top performer lately with year-to-date returns of more than 60% in 2021.\nVistra Corp. (VST)\nDividend yield:3.1%\nA Texas-based utility company, Vistra is an electricity provider -- one of the most stable businesses on Wall Street. But VST also has modest growth potential as it operates in six of the seven wholesale markets where utilities compete for customers, thanks to deregulation. Right now, it has nearly 5 million residential, commercial and industrial connections in about 20 states. Additionally, it announced construction of a 1,600 megawatt-hour battery energy storage system in California, which has captivated investors. Shares have underperformed year to date in 2021, but are up about 30% from their spring lows -- and continue to offer a generous dividend on top of this short-term momentum.","news_type":1},"isVote":1,"tweetType":1,"viewCount":250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802144403,"gmtCreate":1627741208502,"gmtModify":1703495388373,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Positive results","listText":"Positive results","text":"Positive results","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802144403","repostId":"2155137344","repostType":4,"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802347276,"gmtCreate":1627725048895,"gmtModify":1703495248036,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TAL\">$TAL Education Group(TAL)$</a>buy this good stk","listText":"<a href=\"https://laohu8.com/S/TAL\">$TAL Education Group(TAL)$</a>buy this good stk","text":"$TAL Education Group(TAL)$buy this good stk","images":[{"img":"https://static.tigerbbs.com/0b0661e3b8317d74dec39cf7f622983d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802347276","isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802344278,"gmtCreate":1627724956094,"gmtModify":1703495245424,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buy this stk","listText":"Buy this stk","text":"Buy this stk","images":[{"img":"https://static.tigerbbs.com/ff804b0eba336e99dbbea4d9edc3bcb1","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802344278","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802344349,"gmtCreate":1627724929781,"gmtModify":1703495245102,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buy this","listText":"Buy this","text":"Buy this","images":[{"img":"https://static.tigerbbs.com/ff804b0eba336e99dbbea4d9edc3bcb1","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802344349","isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":802572548,"gmtCreate":1627791759984,"gmtModify":1703495956271,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/802572548","repostId":"1159296868","repostType":4,"repost":{"id":"1159296868","pubTimestamp":1627786610,"share":"https://www.laohu8.com/m/news/1159296868?lang=&edition=full","pubTime":"2021-08-01 10:56","market":"us","language":"en","title":"Why Oracle Stock Could Be Volatile In August","url":"https://stock-news.laohu8.com/highlight/detail?id=1159296868","media":"InvestorPlace","summary":"Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce consider","content":"<blockquote>\n Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n</blockquote>\n<p>Once considered a laggard company in the world of technology,<b>Oracle</b>&nbsp;(NYSE:<b>ORCL</b>) stock has made a comeback as one of the best-performing tech names of 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/1e4fb922d429b71a40534256e2dff304\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: Jonathan Weiss / Shutterstock.com</p>\n<p>It was the original champion of database technology. Now Oracle is becoming an emerging force in both backend infrastructure technologies and software-as-a-service (SaaS). In other words, management is proving that what is considered outdated can quickly become hot again in the tech stock space.</p>\n<p>Investors have not been shy to bid ORCL stock up this year. Growth expectations mainly revolve around the cloud computing business. As a result, ORCL stock has soared by 56% over the last 12 months.</p>\n<p>And the rally accelerated after Oracle recently released its fourth-quarter and FY21 results. As a result, the shares hit a record high of $91.20. It currently trades around $87, up 35% in 2021. The current price supports a dividend yield of about 1.3%.</p>\n<p>Thanks to its success in the cloud, Oracle has outperformed many tech stocks currently underperforming the broader market this year. However, in the short run, ORCL stock is likely to be volatile and could see profit-taking</p>\n<p>Yet, long-term investors looking to generate lucrative returns in the rest of 2021 and beyond may consider buying the dips. Here’s why.</p>\n<p><b>How Recent Earnings Came</b></p>\n<p>Founded in 1977, Oracle is well-known for pioneering the first commercial SQL-based relational database management system. Now, with 430,000 customers in 175 countries, the tech giant provides database technology and enterprise resource planning (ERP) software to businesses and global governments. Its market capitalization&nbsp; stands at $246 billion.</p>\n<p>Oracle released&nbsp;fourth-quarter resultsin mid-June. Total revenue increased 8% year-over-year to $11.2 billion. Non-GAAP net income went up buy 20% to $4.5 billion, and non-GAAP earnings per share soared 29% to $1.54.</p>\n<p>In fiscal 2021, Oracle generated almost $13.8 billion in free cash flow. As a result, management invested heavily in stock buybacks. Excluding the $3 billion spent on dividends, it bought back 329 million shares at a cost of $21 billion in the past year. Cash and equivalents ended the fiscal year at $30.1 billion.</p>\n<p>On the results, CEO Safra Catz remarked, “Our Q4 performance was absolutely outstanding with total revenue beating guidance by nearly $200 million, and non-GAAP earnings per share beating guidance by $0.24.”</p>\n<p>Cloud apps saw 20% to 30% growth. Yet, it has not led to a significant increase in overall revenue for the fiscal year 2021. Oracle’s revenue of $40.5 billion grew only by 4% compared to the previous year.</p>\n<p>ORCL stock is currently trading at 19x forward price-earnings multiple and 6.5x current sales. The 12-month price target range for Oracle stock extends from $60 to $115. The median estimate of $80 would mean a decline of about 9% from the current levels. Therefore, short-term investors could see the shares come under pressure.</p>\n<p><b>Long-Term Tailwinds For Oracle Stock</b></p>\n<p>Despite the potential short-term volatility, there are many reasons for investors to consider ORCL stock. It has a broad portfolio addressing different spectrums of enterprise technology. Revenues have been gaining momentum after the company has shifted resources to the cloud space.</p>\n<p>Management regards the cloud in terms of platform, application, and infrastructure layers. Put another way, Oracle offers a complete package that may lead to a even a stronger competitive advantage in the long term.</p>\n<p>The company has recently announced plans to increase spending on data centers. It will double capital expenditures to almost $4 billion. Investors are hoping this heavy spending will boost the cloud businesses.</p>\n<p>Market research firm&nbsp;Research and Markets&nbsp;predicts cloud spending could grow at a compound annual growth rate of 17.5% through 2025. Although this implies a massive opportunity, Oracle currently has a minor share of the broad cloud market.</p>\n<p>The company still trails behind the market leader<b>Amazon</b>(NASDAQ:<b>AMZN</b>) as well as other&nbsp; competitors<b>Microsoft</b>(NASDAQ:<b>MSFT</b>) and&nbsp;<b>Alphabet</b>&nbsp;(NASDAQ:<b>GOOG</b>, NASDAQ:<b>GOOGL</b>). Recent quarterly metrics from these tech giants have shown the importance of cloud applications and services for revenues.</p>\n<p>If management were to continue its recent success, it would be possible to see Oracle grow its market cap to rapidly in the coming quarters as well.</p>\n<p><b>The Bottom Line on ORCL Stock</b></p>\n<p>Oracle’s revenue mix now focuses more on subscriptions, especially in the cloud space. Investors would like to see the bottom line grow in the coming quarters. However, it might still be several quarters before management’s efforts translate into higher earnings.</p>\n<p>Although I remain bullish on ORCL stock for the long run, I expect some profit-taking in the coming weeks Interested investors could regard any drop toward the $80 to $82 level as a better entry point.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Oracle Stock Could Be Volatile In August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Oracle Stock Could Be Volatile In August\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce considered a laggard company in the world of technology,Oracle (NYSE:ORCL) stock has made a comeback as one ...</p>\n\n<a href=\"https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ORCL":"甲骨文"},"source_url":"https://investorplace.com/2021/07/orcl-stock-could-be-volatile-in-august/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159296868","content_text":"Despite short-term profit-taking, ORCL stock should move higher in the coming months.\n\nOnce considered a laggard company in the world of technology,Oracle (NYSE:ORCL) stock has made a comeback as one of the best-performing tech names of 2021.\nSource: Jonathan Weiss / Shutterstock.com\nIt was the original champion of database technology. Now Oracle is becoming an emerging force in both backend infrastructure technologies and software-as-a-service (SaaS). In other words, management is proving that what is considered outdated can quickly become hot again in the tech stock space.\nInvestors have not been shy to bid ORCL stock up this year. Growth expectations mainly revolve around the cloud computing business. As a result, ORCL stock has soared by 56% over the last 12 months.\nAnd the rally accelerated after Oracle recently released its fourth-quarter and FY21 results. As a result, the shares hit a record high of $91.20. It currently trades around $87, up 35% in 2021. The current price supports a dividend yield of about 1.3%.\nThanks to its success in the cloud, Oracle has outperformed many tech stocks currently underperforming the broader market this year. However, in the short run, ORCL stock is likely to be volatile and could see profit-taking\nYet, long-term investors looking to generate lucrative returns in the rest of 2021 and beyond may consider buying the dips. Here’s why.\nHow Recent Earnings Came\nFounded in 1977, Oracle is well-known for pioneering the first commercial SQL-based relational database management system. Now, with 430,000 customers in 175 countries, the tech giant provides database technology and enterprise resource planning (ERP) software to businesses and global governments. Its market capitalization  stands at $246 billion.\nOracle released fourth-quarter resultsin mid-June. Total revenue increased 8% year-over-year to $11.2 billion. Non-GAAP net income went up buy 20% to $4.5 billion, and non-GAAP earnings per share soared 29% to $1.54.\nIn fiscal 2021, Oracle generated almost $13.8 billion in free cash flow. As a result, management invested heavily in stock buybacks. Excluding the $3 billion spent on dividends, it bought back 329 million shares at a cost of $21 billion in the past year. Cash and equivalents ended the fiscal year at $30.1 billion.\nOn the results, CEO Safra Catz remarked, “Our Q4 performance was absolutely outstanding with total revenue beating guidance by nearly $200 million, and non-GAAP earnings per share beating guidance by $0.24.”\nCloud apps saw 20% to 30% growth. Yet, it has not led to a significant increase in overall revenue for the fiscal year 2021. Oracle’s revenue of $40.5 billion grew only by 4% compared to the previous year.\nORCL stock is currently trading at 19x forward price-earnings multiple and 6.5x current sales. The 12-month price target range for Oracle stock extends from $60 to $115. The median estimate of $80 would mean a decline of about 9% from the current levels. Therefore, short-term investors could see the shares come under pressure.\nLong-Term Tailwinds For Oracle Stock\nDespite the potential short-term volatility, there are many reasons for investors to consider ORCL stock. It has a broad portfolio addressing different spectrums of enterprise technology. Revenues have been gaining momentum after the company has shifted resources to the cloud space.\nManagement regards the cloud in terms of platform, application, and infrastructure layers. Put another way, Oracle offers a complete package that may lead to a even a stronger competitive advantage in the long term.\nThe company has recently announced plans to increase spending on data centers. It will double capital expenditures to almost $4 billion. Investors are hoping this heavy spending will boost the cloud businesses.\nMarket research firm Research and Markets predicts cloud spending could grow at a compound annual growth rate of 17.5% through 2025. Although this implies a massive opportunity, Oracle currently has a minor share of the broad cloud market.\nThe company still trails behind the market leaderAmazon(NASDAQ:AMZN) as well as other  competitorsMicrosoft(NASDAQ:MSFT) and Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL). Recent quarterly metrics from these tech giants have shown the importance of cloud applications and services for revenues.\nIf management were to continue its recent success, it would be possible to see Oracle grow its market cap to rapidly in the coming quarters as well.\nThe Bottom Line on ORCL Stock\nOracle’s revenue mix now focuses more on subscriptions, especially in the cloud space. Investors would like to see the bottom line grow in the coming quarters. However, it might still be several quarters before management’s efforts translate into higher earnings.\nAlthough I remain bullish on ORCL stock for the long run, I expect some profit-taking in the coming weeks Interested investors could regard any drop toward the $80 to $82 level as a better entry point.","news_type":1},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830779358,"gmtCreate":1629103114874,"gmtModify":1676529930630,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRNVR\">$Greenvision Acquisition Corp. Rights(GRNVR)$</a>How can i sell this one.This stock is delisted.","listText":"<a href=\"https://laohu8.com/S/GRNVR\">$Greenvision Acquisition Corp. Rights(GRNVR)$</a>How can i sell this one.This stock is delisted.","text":"$Greenvision Acquisition Corp. Rights(GRNVR)$How can i sell this one.This stock is delisted.","images":[{"img":"https://static.tigerbbs.com/f7c5e1bc32c5629f9abb3b6e60e7af27","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/830779358","isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3564387851823420","authorId":"3564387851823420","name":"ememe","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"content":"I have no Man Cang","text":"I have no Man Cang","html":"I have no Man Cang"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802347276,"gmtCreate":1627725048895,"gmtModify":1703495248036,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TAL\">$TAL Education Group(TAL)$</a>buy this good stk","listText":"<a href=\"https://laohu8.com/S/TAL\">$TAL Education Group(TAL)$</a>buy this good stk","text":"$TAL Education Group(TAL)$buy this good stk","images":[{"img":"https://static.tigerbbs.com/0b0661e3b8317d74dec39cf7f622983d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802347276","isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805446022,"gmtCreate":1627902606966,"gmtModify":1703497509997,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805446022","repostId":"2156212196","repostType":4,"repost":{"id":"2156212196","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627890622,"share":"https://www.laohu8.com/m/news/2156212196?lang=&edition=full","pubTime":"2021-08-02 15:50","market":"sh","language":"en","title":"China shares jump after worst month in nearly 3 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2156212196","media":"Reuters","summary":"SSEC up 1.97%, CSI300 up 2.55%\nForeigners lend support as net buyers through Stock Connect\nNew Delta","content":"<ul>\n <li>SSEC up 1.97%, CSI300 up 2.55%</li>\n <li>Foreigners lend support as net buyers through Stock Connect</li>\n <li>New Delta variant virus cases continue to rise</li>\n <li>China government bond yields lowest in more than 1 year</li>\n</ul>\n<p>SHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.</p>\n<p>The Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index&nbsp;ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.</p>\n<p>The gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.</p>\n<p>\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.</p>\n<p>\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"</p>\n<p>Both the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.</p>\n<p>Those concerns also weighed on the fixed income market, where benchmark Chinese government bond <a href=\"https://laohu8.com/S/CGB.AU\">$(CGB.AU)$</a> yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.</p>\n<p>Adding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.</p>\n<p>But by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.</p>\n<p>Data from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).</p>\n<p>\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.</p>\n<p>($1 = 6.4631 Chinese yuan)</p>\n<p>(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China shares jump after worst month in nearly 3 years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina shares jump after worst month in nearly 3 years\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-02 15:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SSEC up 1.97%, CSI300 up 2.55%</li>\n <li>Foreigners lend support as net buyers through Stock Connect</li>\n <li>New Delta variant virus cases continue to rise</li>\n <li>China government bond yields lowest in more than 1 year</li>\n</ul>\n<p>SHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.</p>\n<p>The Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index&nbsp;ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.</p>\n<p>The gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.</p>\n<p>\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.</p>\n<p>\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"</p>\n<p>Both the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.</p>\n<p>Those concerns also weighed on the fixed income market, where benchmark Chinese government bond <a href=\"https://laohu8.com/S/CGB.AU\">$(CGB.AU)$</a> yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.</p>\n<p>Adding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.</p>\n<p>But by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.</p>\n<p>Data from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).</p>\n<p>\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.</p>\n<p>($1 = 6.4631 Chinese yuan)</p>\n<p>(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156212196","content_text":"SSEC up 1.97%, CSI300 up 2.55%\nForeigners lend support as net buyers through Stock Connect\nNew Delta variant virus cases continue to rise\nChina government bond yields lowest in more than 1 year\n\nSHANGHAI, Aug 2 (Reuters) - Chinese shares jumped on Monday, with the benchmark indexes logging their biggest daily gains since May, as investors snapped up stocks battered by a sell-off last month.\nThe Shanghai Composite index finished the day up 1.97% at 3,464.29 points and the blue-chip CSI300 index ended 2.55% higher. It was the biggest daily rise since May 25 for both indexes.\nThe gains follow a near 5.5% fall for the CSI300 last week, capping its biggest monthly loss since October 2018 after a string of regulatory moves aimed at the after-school education, tech and property sectors.\n\"I think the China A-share market became an unnecessary victim of the recent regulatory events. The so-called 'clampdown' is really just on a few sectors and Chinese ADRs rather than A-shares in general,\" said Qi Wang, chief executive officer at MegaTrust Investment in Hong Kong.\n\"Seriously, what's the connection between closing down cram schools and people consuming more or less liquor, for example? I don't see any.\"\nBoth the CSI300 and Shanghai Composite indexes had fallen around 1% in early trade on rising concerns over a domestic surge in Delta variant COVID-19 infections. China on Monday reported 98 new confirmed coronavirus cases in the mainland for the day earlier, the highest daily rise since Jan. 24.\nThose concerns also weighed on the fixed income market, where benchmark Chinese government bond $(CGB.AU)$ yields dropped to their lowest level in more than a year. The most-traded CGB futures contract for September delivery ended up 0.23%.\nAdding to worries over the economic outlook, a private sector survey showed China's factory activity growth fell to a 15-month low in July.\nBut by mid-morning, investors' focus shifted to the attractive valuations of stocks after last week's rout. The CSI300 financial sector sub-index finished up 2.2% and the consumer staples sector jumped 4.85%.\nData from Refinitiv showed foreign investors were net buyers of A-shares on Monday, with inflows through the Northbound leg of the Stock Connect programme topping 9.55 billion yuan ($1.48 billion).\n\"We believe short-term volatility creates opportunities for long-term investors. The A-share market should resume an upward trajectory after domestic credit growth bottoms,\" Meng Lei, A-share strategist at UBS Securities said in an emailed comment.\n($1 = 6.4631 Chinese yuan)\n(Reporting by Andrew Galbraith; Editing by Sam Holmes and Amy Caren Daniel)","news_type":1},"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802144403,"gmtCreate":1627741208502,"gmtModify":1703495388373,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Positive results","listText":"Positive results","text":"Positive results","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802144403","repostId":"2155137344","repostType":4,"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893228420,"gmtCreate":1628265780360,"gmtModify":1703504343875,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watch list","listText":"Watch list","text":"Watch list","images":[{"img":"https://static.tigerbbs.com/87f227d930393cb90f74ae65676aab38","width":"1080","height":"3279"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893228420","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890408151,"gmtCreate":1628126512973,"gmtModify":1703501672029,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Going down...until when","listText":"Going down...until when","text":"Going down...until when","images":[{"img":"https://static.tigerbbs.com/63fb88b669db74915d3fc40d6a94d1f7","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890408151","isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":807469704,"gmtCreate":1628050783208,"gmtModify":1703500301467,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watchlist","listText":"Watchlist","text":"Watchlist","images":[{"img":"https://static.tigerbbs.com/f3e05fe9d4c70af016eb1fdff5bf58a0","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807469704","isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804854112,"gmtCreate":1627951020036,"gmtModify":1703498364411,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Kept watchlist","listText":"Kept watchlist","text":"Kept watchlist","images":[{"img":"https://static.tigerbbs.com/b2261375a267fff142acb64ecba6883d","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804854112","isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805448303,"gmtCreate":1627902563202,"gmtModify":1703497508515,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805448303","repostId":"2156191887","repostType":4,"repost":{"id":"2156191887","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627893983,"share":"https://www.laohu8.com/m/news/2156191887?lang=&edition=full","pubTime":"2021-08-02 16:46","market":"us","language":"en","title":"India says J&J withdraws proposal for speedy vaccine approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2156191887","media":"Reuters","summary":"(Adds details, background)\nBENGALURU, Aug 2 (Reuters) - India's drug regulator said on Monday that J","content":"<p>(Adds details, background)</p>\n<p>BENGALURU, Aug 2 (Reuters) - India's drug regulator said&nbsp;on Monday that Johnson &amp; Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.</p>\n<p>The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports&nbsp;of rare blood clots.</p>\n<p>The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.</p>\n<p>\"This team is in continuous dialogue with Pfizer, Moderna and Johnson &amp; Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.</p>\n<p>Johnson &amp; Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.</p>\n<p>As of July 31, Johnson &amp; Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> , and Moderna Inc have already sought full approval of their vaccines with the FDA.</p>\n<p>In India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.</p>\n<p>(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>India says J&J withdraws proposal for speedy vaccine approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndia says J&J withdraws proposal for speedy vaccine approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-02 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Adds details, background)</p>\n<p>BENGALURU, Aug 2 (Reuters) - India's drug regulator said&nbsp;on Monday that Johnson &amp; Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.</p>\n<p>The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports&nbsp;of rare blood clots.</p>\n<p>The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.</p>\n<p>\"This team is in continuous dialogue with Pfizer, Moderna and Johnson &amp; Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.</p>\n<p>Johnson &amp; Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.</p>\n<p>As of July 31, Johnson &amp; Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> , and Moderna Inc have already sought full approval of their vaccines with the FDA.</p>\n<p>In India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.</p>\n<p>(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156191887","content_text":"(Adds details, background)\nBENGALURU, Aug 2 (Reuters) - India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details.\nThe U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the United States at that time were paused on reports of rare blood clots.\nThe drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage with vaccine makers.\n\"This team is in continuous dialogue with Pfizer, Moderna and Johnson & Johnson to discuss and address various issues including the issue of indemnity,\" Bharati Pravin Pawar had said.\nJohnson & Johnson and the Central Drugs Standard Control Organisation (CDSCO) did not immediately respond to Reuters' requests for comments on why the company withdrew its application.\nAs of July 31, Johnson & Johnson is yet to request a full approval for its shot with the U.S. FDA, while Pfizer Inc, BioNTech SE , and Moderna Inc have already sought full approval of their vaccines with the FDA.\nIn India, the drug regulator had given emergency use authorisation to Moderna's vaccine in June.\n(Reporting by Shivani Singh in Bengaluru; editing by Uttaresh.V)","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802438840,"gmtCreate":1627794119480,"gmtModify":1703495995058,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keep watchlist","listText":"Keep watchlist","text":"Keep watchlist","images":[{"img":"https://static.tigerbbs.com/1d83e9dc6c292359747107d732b0a7d2","width":"1080","height":"3487"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802438840","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802344278,"gmtCreate":1627724956094,"gmtModify":1703495245424,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buy this stk","listText":"Buy this stk","text":"Buy this stk","images":[{"img":"https://static.tigerbbs.com/ff804b0eba336e99dbbea4d9edc3bcb1","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802344278","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802344349,"gmtCreate":1627724929781,"gmtModify":1703495245102,"author":{"id":"3583733168961193","authorId":"3583733168961193","name":"snb","avatar":"https://static.tigerbbs.com/6d51c6c66532670c56582c27e510f0ad","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buy this","listText":"Buy this","text":"Buy this","images":[{"img":"https://static.tigerbbs.com/ff804b0eba336e99dbbea4d9edc3bcb1","width":"1080","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802344349","isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}